| |
|
|
|
|
|
|
 |
|
|
 Serzone
is an antidepressant manufactured by Bristol-Myers Squibb.
The generic name for Serzone is nefazodone
hydrochloride. Serzone was approved by the FDA
for use in the United States for the treatment of depression
in 1994.
In December of 2001, The Food and Drug Administration
notified Bristol-Myers Squibb Co. that it must include
a black-box warning on the Serzone
label, advising patients that rare but possibly life-threatening
liver failure can occur with use of the drug.
A black-box warning label is the most serious warning
issued by the Federal Food and Drug Administration. The
FDA will also soon require Serzone's manufacturer to warn
doctors that patients could suffer severe liver failure
that could lead to death or necessitate a liver transplant.
On January 8th, 2003, Serzone was removed
from the market in all European countries because it had
been linked to 26 deaths from liver damage.
Some symptoms of liver complications include: yellowing
of the skin or the whites of the eyes (jaundice), dark
urine, loss of appetite that lasts several days or longer,
nausea, and abdominal pain.
Serzone patients with any of these symptoms should report
them to their doctor immediately. To determine if you
might have a Serzone claim based on any adverse side effects,
please call us for a
-- or send us an instant e-mail
and we will respond within 24 hours.
Disclaimer:
Colorado Serzone Side Effects Attorney Disclaimer: Denver
and Breckenridge Serzone / pharmaceutical litigation and/or
other legal information offered herein by Gempeler Trial
Lawyers is not formal legal advice, nor the formation
of an attorney client relationship. Each case is different
and the outcome of your personal injury case will depend
on the merits of your factual situation and applicable
law. An Attorney-Client relationship is not created by
visiting this web site. No Attorney-Client relationship
is created until a retainer agreement is signed.
|
|
 |
|
 |
|
|
|
